查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1347709

心臟假體設備市場：2023-2028 年全球行業趨勢、佔有率、規模、成長、機遇和預測

Cardiac Prosthetic Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3個工作天內

價格

2023-2028 年市場概覽：

2022年，全球心臟假體器械市場規模達到62億美元。展望未來，IMARC Group預計到2028年市場規模將達到100億美元，2023-2028年年複合成長率（CAGR）為8.1%。緊湊型起搏器和免縫合瓣膜置換術的發展、微創（MI）手術的日益成長以及大眾心血管疾病患病率的上升是推動該市場的一些主要因素。

心臟假體裝置是指設計用於替代或輔助心臟正常功能的人造裝置或植入物。它們用於治療各種心臟疾病，例如心力衰竭、瓣膜疾病或先天性心臟缺陷。它們大致可分為兩種類型：人工心臟瓣膜和機械循環支持裝置。人造心臟瓣膜用於替換受損或患病的心臟瓣膜，恢復流經心臟的正常血流。另一方面，機械循環支持裝置用於輔助或替代心臟的泵血功能，通常用作移植的橋樑或作為不適合心臟移植的患者的長期解決方案。此外，它們由生物相容性材料製成，經過精心設計，可複製心臟的結構和功能，從而改善患者的心臟功能和生活品質。

該行業是由全球人口老齡化推動的。隨著人口持續老齡化，心血管疾病的發病率增加，導致對心臟假體裝置的需求更高。此外，醫療技術和外科技術的不斷進步提高了心血管疾病患者的生存率，這為這些設備創造了更大的患者庫。與此同時，大眾對心血管健康的認知不斷提高以及治療方案的可用性正在推動產品需求。此外，患者正在尋求及時的干涉措施，包括使用心臟假體裝置，以提高生活品質並延長生存期，這對市場產生了積極影響。其他因素，包括醫療保健行業的持續發展以及主要參與者進行的廣泛研發（R＆D）活動，也對市場產生積極影響。

心臟假體設備市場趨勢/促進因素：

心血管疾病的患病率及其意識的提高

心血管疾病，包括冠狀動脈疾病、心力衰竭和瓣膜性心臟病，是全球發病率和死亡率的重要原因。此外，人們對心臟病、預防措施和治療方案的認知不斷提高，從而可以更早地發現和診斷心血管疾病。診斷能力的提高，包括超聲心動圖和心臟 MRI 等先進成像技術，有助於準確診斷和識別可能受益於心臟假體裝置的患者。公眾意識的提高和多種疾病患病率的上升共同導致了產品需求的增加。隨著越來越多的人在早期被診斷出患有心血管疾病，越來越多的患者可以從涉及心臟修復術的干涉措施中受益。

落實優惠報銷政策

報銷在心臟假體裝置的採用中發揮著至關重要的作用。政府醫療保健系統和私人保險提供商提供的優惠報銷政策激勵醫療保健提供商向患者提供這些設備和程序。這為市場成長創造了有利的環境，因為它減少了患者的經濟障礙並促進了心臟假體設備的使用。此外，不斷增加的疾病負擔和醫療技術的進步正在增加全球的醫療保健支出。醫療保健支出的增加有助於提高心臟假體設備的可負擔性和可及性，從而使有需要的患者能夠更廣泛地獲得它們。除此之外，市場參與者正在建立夥伴關係、協作和分銷網路，這是另一個成長誘導因素。

心臟手術技術和設備的持續技術創新

心臟外科技術的不斷進步，如微創手術、機器人輔助手術和經導管介入治療，擴大了治療各種心臟疾病的範圍。這些進步提高了產品的利用率，包括心臟瓣膜、心室輔助裝置 (VAD) 和起搏器，因為它們在這些手術中發揮著至關重要的作用。技術的快速進步徹底改變了心臟假體設備的設計和功能。例如，經導管心臟瓣膜的發展使得微創瓣膜置換手術成為可能，減少了患者的創傷和恢復時間。此外，起搏器和植入式心律轉復除顫器 (ICD) 中無線連接、遠程監控功能和先進感測器的整合改善了患者護理和結果，創造了積極的市場前景。

心臟假體器械行業細分：

IMARC Group 提供了全球心臟假體設備報告各個部分的主要趨勢分析，以及 2023 年至 2028 年全球、區域和國家層面的預測。我們的報告根據產品類型和最終用戶對市場進行了分類。

按產品類型分類：

閥門

機械閥

組織閥

支架組織瓣膜

無支架組織瓣膜

經導管瓣膜

起搏器

植入式起搏器

單室電池起搏器

雙室電池起搏器

三室電池起搏器

體外起搏器

其他

閥門主導市場

該報告根據產品類型對市場進行了詳細的細分和分析。這包括瓣膜（機械瓣膜、組織瓣膜、帶支架組織瓣膜、無支架組織瓣膜和經導管瓣膜）、起搏器、植入式起搏器（單腔電池起搏器、雙腔電池起搏器和三腔電池起搏器）、體外起搏器， 和別的。根據該報告，閥門代表了最大的細分市場。

閥門設計和材料的持續技術進步提高了設備​​的耐用性、功能和整體性能，從而獲得了更大的接受和採用。此外，對微創手術的日益關注和經導管心臟瓣膜置換技術的發展正在積極影響對瓣膜產品的需求。

此外，醫療技術的不斷進步促進了創新起搏器設備的開發，這些設備具有改進的特性和功能，包括無線連接和遠程監控功能，這進一步推動了市場成長。此外，肥胖和糖尿病等與生活方式相關的疾病患病率不斷上升，這些疾病是心臟病的危險因素，正在推動全球對起搏器的需求。

按最終用戶分類：

醫院、診所和心臟中心

門診手術中心

其他

醫院、診所和心臟中心佔據最大的市場佔有率

報告還提供了基於最終用戶的詳細市場細分和分析。這包括醫院、診所和心臟中心、門診手術中心等。報告稱，醫院、診所和心臟中心佔據了最大的市場佔有率。

這些設備在醫院、診所和心臟中心的使用越來越多，可歸因於醫療技術和外科技術的不斷進步。人造心臟瓣膜和植入式起搏器等創新設備的不斷發展，使醫療保健提供者能夠為患者提供改進的治療選擇。此外，旨在加強心血管護理和改善患者治療效果的各種政府舉措和醫療改革也成為該行業最終用戶的主要市場驅動力。

相反，門診手術中心（ASC）作為心臟領域的最終用戶提供了許多優勢，例如成本效益、便利性和減少住院時間，這對尋求心臟手術的患者特別有吸引力。這些中心為微創手術和門診治療提供了合適的環境，符合基於價值的醫療保健日益成長的趨勢。此外，技術的進步使得在 ASC 中執行複雜的心臟手術成為可能，從而進一步推動了預測期內該領域的市場需求。

按地區分類：

北美

美國

加拿大

亞太地區

中國

日本

印度

韓國

澳大利亞

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

北美表現出明顯的主導地位，佔據最大的心臟假體設備市場佔有率

該報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；亞太地區（中國、日本、印度、韓國、澳大利亞、印尼等）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。

北美市場的驅動力是心血管疾病患病率的增加和人口老齡化的加劇。隨著心臟相關疾病變得越來越普遍，對心臟瓣膜、起搏器和植入式除顫器等設備的需求不斷成長。此外，該地區的醫療保健系統專注於高品質的醫療保健服務，並且對醫療設備的報銷支持也在市場的成長中發揮著重要作用。此外，旨在開發創新和微創假肢裝置的研發工作正在大力支持市場。

相反，由於人口老齡化和生活方式的改變，亞太地區預計未來幾年該領域將進一步擴張。與此同時，亞太地區一些國家醫療基礎設施的進步和可支配收入的增加改善了醫療服務的可及性並提高了負擔能力。此外，該領域持續的技術進步和創新正在推動亞太地區的市場。

競爭格局：

由於醫療技術和外科手術的不斷進步，導致創新和更高效的設備的開發，市場正在經歷顯著成長。此外，數位健康技術的整合為公司提供遠程監控解決方案和個性化醫療服務、改善患者治療效果並提高其產品的整體價值主張創造了機會。此外，許多公司正在開發客製化解決方案來滿足特定患者的需求，這在全球範圍內越來越受到重視。此外，3D列印技術的發展進一步促進了患者專用設備的生產，從而實現更好的貼合性和改進的功能。此外，頂級公司正在投資研發以創建可客製化的解決方案，並與醫療保健專業人員合作以了解患者的需求，這正在影響市場。

該報告對市場競爭格局進行了全面分析。還提供了所有主要公司的詳細資料。市場上的一些主要參與者包括：

雅培實驗室

百多力

波士頓科學公司

愛德華茲生命科學公司

樂普醫療科技有限公司

美敦力公司

梅里爾生命科學列兵。有限公司

西門子醫療保健有限公司

索林集團

聖裘德醫療公司

最近的發展：

2021 年 9 月，雅培實驗室宣布該公司的 Epic Plus 和 Epic Plus Supra 支架組織瓣膜已獲得 FDA 批准，擴大了主動脈瓣或二尖瓣功能障礙患者的治療選擇。

2020年1月，美敦力公司宣布其Cobalt和Crome心臟再同步治療除顫器（CRT-D）和植入式心臟復律除顫器（ICD）獲得歐盟CE標誌認證，允許其進入歐洲大陸。

2019年6月，百多力宣布推出其著名的注射式心臟監測儀BIOMONITOR的新型號。雖然 BIOMONITOR III 比 BIOMONITOR 2 小得多，但它提供了更清晰的訊號品質。

本報告回答的關鍵問題：

  • 迄今為止，全球心臟假體設備市場表現如何，未來幾年將如何表現？
  • 全球心臟假體器械市場的促進因素、限制因素和機遇是什麼？
  • 每個促進因素、限制因素和機會對全球心臟假體器械市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的心臟假體設備市場？
  • 根據產品類型分類的市場是怎樣的？
  • 心臟假體器械市場中最具吸引力的產品類型是什麼？
  • 基於最終用戶的市場細分是什麼？
  • 哪一個是心臟假體設備市場中最具吸引力的最終用戶？
  • 全球心臟假體器械市場的競爭結構如何？
  • 全球心臟假體器械市場的主要參與者/公司有哪些？

本報告回答的關鍵問題：

  • 迄今為止，全球心臟假體設備市場表現如何，未來幾年將如何表現？
  • 全球心臟假體器械市場的促進因素、限制因素和機遇是什麼？
  • 每個促進因素、限制因素和機會對全球心臟假體器械市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的心臟假體設備市場？
  • 根據產品類型分類的市場是怎樣的？
  • 心臟假體器械市場中最具吸引力的產品類型是什麼？
  • 基於最終用戶的市場細分是什麼？
  • 哪一個是心臟假體設備市場中最具吸引力的最終用戶？
  • 全球心臟假體器械市場的競爭結構如何？
  • 全球心臟假體器械市場的主要參與者/公司有哪些？

目錄

第一章：前言

第 2 章：範圍和方法

  • 研究目的
  • 利益相關者
  • 數據源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球心臟假體器械市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：按產品類型分類的市場細分

  • 閥門
    • 市場走向
    • 主要類型
      • 機械閥
      • 組織閥
      • 支架組織瓣膜
      • 無支架組織瓣膜
      • 經導管瓣膜
    • 市場預測
  • 起搏器
    • 市場走向
    • 市場預測
  • 植入式起搏器
    • 市場走向
    • 主要類型
      • 單室電池起搏器
      • 雙室電池起搏器
      • 三室電池起搏器
    • 市場預測
  • 體外起搏器
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：最終用戶的市場細分

  • 醫院、診所和心臟中心
    • 市場走向
    • 市場預測
  • 門診手術中心
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：按地區分類的市場細分

  • 北美
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太地區
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳大利亞
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 9 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 10 章：價值鏈分析

第 11 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 12 章：價格分析

第13章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Biotronik
    • Boston Scientific Corporation
    • Edwards Lifesciences Corporation
    • Lepu Medical Technology Co. Ltd.
    • Medtronic Inc.
    • Meril Life Sciences Pvt. Ltd.
    • Siemens Healthcare GmbH
    • Sorin Group
    • St. Jude Medical Inc.
Product Code: SR112023A2037

Market Overview 2023-2028:

The global cardiac prosthetic devices market size reached US$ 6.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.0 Billion by 2028, exhibiting a growth rate (CAGR) of 8.1% during 2023-2028. The development of compact pacemakers and suture-less valve replacements, the growing inclination toward minimally invasive (MI) procedures, and the rising prevalence of cardiovascular disorders among the masses are some of the major factors propelling the market.

Cardiac prosthetic devices refer to artificial devices or implants designed to replace or assist the normal functioning of the heart. They are used in the treatment of various heart conditions, such as heart failure, valve disorders, or congenital heart defects. They can be broadly categorized into two types, artificial heart valves and mechanical circulatory support devices. Artificial heart valves are used to replace damaged or diseased heart valves, restoring normal blood flow through the heart. On the other hand, mechanical circulatory support devices are used to assist or replace the pumping function of the heart, often employed as a bridge to transplantation or as a long-term solution for patients ineligible for heart transplantation. Additionally, they are manufactured of biocompatible materials and are meticulously designed to replicate the structure and function of the heart, thereby improving the patient's cardiac function and quality of life.

The industry is driven by the aging global population. As the population continues to age, the incidence of cardiovascular diseases increases, leading to a higher demand for cardiac prosthetic devices. Additionally, continual advancements in medical technology and surgical techniques have improved the survival rates of patients with cardiovascular diseases, this is creating a larger patient pool for these devices. Along with this, the increasing awareness about cardiovascular health and the availability of treatment options among the masses is fueling the product demand. Also, patients are seeking timely interventions, including the use of cardiac prosthetic devices, to improve their quality of life and prolong survival, which is positively influencing the market. Other factors, including continual developments in the healthcare sector and extensive research and development (R&D) activities conducted by key players, are also positively influencing the market.

Cardiac Prosthetic Devices Market Trends/Drivers:

Increasing Prevalence of Cardiovascular Diseases and their Awareness

Cardiovascular diseases, including coronary artery disease, heart failure, and valvular heart diseases, are significant contributors to morbidity and mortality across the globe. Additionally, the increasing awareness about heart diseases, preventive measures, and the availability of treatment options has led to earlier detection and diagnosis of cardiovascular conditions. Improved diagnostic capabilities, including advanced imaging techniques, such as echocardiography and cardiac MRI, facilitate accurate diagnosis and identification of patients who may benefit from cardiac prosthetic devices. The combination of public awareness and the rising prevalence of numerous diseases has led to an increasing product demand. As more individuals are diagnosed with CVDs at an earlier stage, there is a growing pool of patients who could benefit from interventions involving cardiac prosthetics.

The Implementation of Favorable Reimbursement Policies

Reimbursement plays a vital role in the adoption of cardiac prosthetic devices. Favorable reimbursement policies offered by government healthcare systems and private insurance providers incentivize healthcare providers to offer these devices and procedures to their patients. This creates a conducive environment for market growth, as it reduces financial barriers for patients and promotes the use of cardiac prosthetic devices. In addition, the rising disease burden, and advances in medical technology are increasing healthcare expenditure across the globe. This higher healthcare spending is contributing to the affordability and accessibility of cardiac prosthetic devices, making them more widely available to patients in need. Besides this, market players are establishing partnerships, collaborations, and distribution networks, which are acting as another growth-inducing factor.

Continual Technological Innovations in Cardiac Surgery Techniques and Devices

Continuous advancements in cardiac surgical techniques, such as minimally invasive procedures, robotic-assisted surgeries, and transcatheter interventions, have expanded the scope of treating various cardiac conditions. These advancements have increased product utilization, including heart valves, ventricular assist devices (VADs), and pacemakers, as they play a crucial role in these procedures. Rapid advancements in technology have revolutionized the design and functionality of cardiac prosthetic devices. For instance, the development of transcatheter heart valves has enabled less invasive valve replacement procedures, reducing patient trauma and recovery time. Additionally, the integration of wireless connectivity, remote monitoring capabilities, and advanced sensors in pacemakers and implantable cardioverter-defibrillators (ICDs) has improved patient care and outcomes, creating a positive market outlook.

Cardiac Prosthetic Devices Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global cardiac prosthetic devices report, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on product type and end-user.

Breakup by Product Type:

Valves

Mechanical Valve

Tissue Valve

Stented Tissue Valve

Stentless Tissue Valve

Transcatheter Valve

Pacemakers

Implantable Pacemakers

Single-Chamber Battery Pacemaker

Dual-Chamber Battery Pacemaker

Triple-Chamber Battery Pacemaker

External Pacemakers

Others

Valves dominate the market

The report has provided a detailed breakup and analysis of the market based on the product type. This includes valves (mechanical valve, tissue valve, stented tissue valve, stentless tissue valve, and transcatheter valve), pacemakers, implantable pacemakers (single-chamber battery pacemaker, dual-chamber battery pacemaker, and triple-chamber battery pacemaker), external pacemakers, and others. According to the report, valves represented the largest segment.

Continual technological advancements in valve design and materials have improved the durability, functionality, and overall performance of devices, leading to greater acceptance and adoption. Additionally, the increasing focus on minimally invasive procedures and the development of transcatheter heart valve replacement techniques are positively influencing the demand for valve products.

Additionally, continuous advancements in medical technology have led to the development of innovative pacemaker devices with improved features and functionalities, including wireless connectivity and remote monitoring capabilities, which further drive market growth. Moreover, the rising prevalence of lifestyle-related diseases, such as obesity and diabetes, which are risk factors for heart ailments, is fueling the demand for pacemakers across the globe.

Breakup by End-User:

Hospitals, Clinics and Cardiac Centers

Ambulatory Surgical Centers

Others

Hospitals, clinics and cardiac centers hold the largest share in the market

A detailed breakup and analysis of the market based on the end-user has also been provided in the report. This includes hospitals, clinics and cardiac centers, ambulatory surgical centers, and others. According to the report, hospitals, clinics, and cardiac centers accounted for the largest market share.

The increasing usage of these devices in hospitals, clinics, and cardiac centers can be attributed to the continual advancements in medical technology and surgical techniques. The continuous development of innovative devices, such as artificial heart valves and implantable pacemakers, enables healthcare providers to offer improved treatment options to patients. Furthermore, various government initiatives and healthcare reforms aimed at enhancing cardiovascular care and improving patient outcomes also serve as major market drivers for the end-users in the industry.

On the contrary, ambulatory surgical centers (ASCs) as end-users in the cardiac offer numerous advantages, such as cost-effectiveness, convenience, and reduced hospital stays, which are particularly appealing to patients seeking cardiac procedures. These centers provide a suitable environment for minimally invasive surgeries and outpatient treatments, aligning with the growing trend towards value-based healthcare. Additionally, advancements in technology have made it feasible to perform complex cardiac procedures in ASCs, further fueling the market demand in this segment over the forecast period.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest the cardiac prosthetic devices market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

The market in North America is driven by the increasing prevalence of cardiovascular diseases and the growing aging population. As heart-related conditions become more common, the need for devices such as heart valves, pacemakers, and implantable defibrillators is growing. Additionally, the healthcare system across the region focuses on quality healthcare delivery and reimbursement support for medical devices also plays a significant role in the growth of the market. Moreover, research and development efforts aimed at developing innovative and minimally invasive prosthetic devices are significantly supporting the market.

On the contrary, Asia Pacific is estimated to expand further in this domain in the coming years due to the aging population and changing lifestyles. In confluence with this, advancements in healthcare infrastructure and the rising disposable income in several countries within the Asia Pacific region have improved access to medical treatments and increased affordability. Furthermore, ongoing technological advancements and innovations in the field are driving the market in Asia Pacific.

Competitive Landscape:

The market is experiencing significant growth due to the continual advancements in medical technology and surgical procedures leading to the development of innovative and more efficient devices. Additionally, the integration of digital health technologies is creating opportunities for companies to offer remote monitoring solutions and personalized healthcare services, enhancing patient outcomes and increasing the overall value proposition of their products. Also, numerous companies are developing tailored solutions to address specific patient needs, this is gaining prominence across the globe. Moreover, the development of 3D printing technology has further facilitated the production of patient-specific devices, allowing for better fit and improved functionality. Additionally, top companies are investing in research and development to create customizable solutions and collaborate with healthcare professionals to understand patient requirements, which is influencing the market.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

Biotronik

Boston Scientific Corporation

Edwards Lifesciences Corporation

Lepu Medical Technology Co. Ltd.

Medtronic Inc.

Meril Life Sciences Pvt. Ltd.

Siemens Healthcare GmbH

Sorin Group

St. Jude Medical Inc.

Recent Developments:

In September 2021, Abbott Laboratories announced that the company's Epic Plus and Epic Plus Supra Stented Tissue Valves have received FDA approval, expanding treatment options for patients with aortic or mitral valve dysfunction.

In January 2020, Medtronic Inc. announced that its Cobalt and Crome cardiac resynchronization therapy-defibrillators (CRT-D) and implanted cardioverter-defibrillators (ICD) received EU CE Mark certification, permitting their entry to the continent.

In June 2019, Biotronik announced the release of a new model of its well-known injectable heart monitor, BIOMONITOR. While being significantly smaller than the BIOMONITOR 2, the BIOMONITOR III provides a substantially crisper signal quality.

Key Questions Answered in This Report:

  • How has the global cardiac prosthetic devices market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global cardiac prosthetic devices market?
  • What is the impact of each driver, restraint, and opportunity on the global cardiac prosthetic devices market?
  • What are the key regional markets?
  • Which countries represent the most attractive cardiac prosthetic devices market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the cardiac prosthetic devices market?
  • What is the breakup of the market based on the end-user?
  • Which is the most attractive end-user in the cardiac prosthetic devices market?
  • What is the competitive structure of the global cardiac prosthetic devices market?
  • Who are the key players/companies in the global cardiac prosthetic devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cardiac Prosthetic Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Valves
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Mechanical Valve
      • 6.1.2.2 Tissue Valve
      • 6.1.2.3 Stented Tissue Valve
      • 6.1.2.4 Stentless Tissue Valve
      • 6.1.2.5 Transcatheter Valve
    • 6.1.3 Market Forecast
  • 6.2 Pacemakers
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Implantable Pacemakers
    • 6.3.1 Market Trends
    • 6.3.2 Major Types
      • 6.3.2.1 Single-Chamber Battery Pacemaker
      • 6.3.2.2 Dual-Chamber Battery Pacemaker
      • 6.3.2.3 Triple-Chamber Battery Pacemaker
    • 6.3.3 Market Forecast
  • 6.4 External Pacemakers
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by End-User

  • 7.1 Hospitals, Clinics and Cardiac Centers
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Ambulatory Surgical Centers
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
    • 13.3.2 Biotronik
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Boston Scientific Corporation
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Edwards Lifesciences Corporation
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Lepu Medical Technology Co. Ltd.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 Medtronic Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 Meril Life Sciences Pvt. Ltd.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Siemens Healthcare GmbH
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Sorin Group
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 St. Jude Medical Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Cardiac Prosthetic Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Cardiac Prosthetic Devices Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Cardiac Prosthetic Devices Market: Breakup by Product Type (in %), 2022
  • Figure 4: Global: Cardiac Prosthetic Devices Market: Breakup by End-User (in %), 2022
  • Figure 5: Global: Cardiac Prosthetic Devices Market: Breakup by Region (in %), 2022
  • Figure 6: Global: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 7: Global: Cardiac Prosthetic Devices (Valves) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 8: Global: Cardiac Prosthetic Devices (Valves) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 9: Global: Cardiac Prosthetic Devices (Pacemakers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Cardiac Prosthetic Devices (Pacemakers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Cardiac Prosthetic Devices (Implantable Pacemakers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Cardiac Prosthetic Devices (Implantable Pacemakers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Cardiac Prosthetic Devices (External Pacemakers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Cardiac Prosthetic Devices (External Pacemakers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Cardiac Prosthetic Devices (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Cardiac Prosthetic Devices (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Cardiac Prosthetic Devices (Hospitals, Clinics and Cardiac Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Cardiac Prosthetic Devices (Hospitals, Clinics and Cardiac Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Cardiac Prosthetic Devices (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Cardiac Prosthetic Devices (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Cardiac Prosthetic Devices (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Cardiac Prosthetic Devices (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: North America: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: North America: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: United States: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: United States: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Canada: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Canada: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Asia Pacific: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Asia Pacific: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: China: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: China: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Japan: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Japan: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: India: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: India: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: South Korea: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: South Korea: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Australia: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Australia: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Indonesia: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Indonesia: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Others: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Others: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Europe: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Europe: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Germany: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Germany: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: France: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: France: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: United Kingdom: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: United Kingdom: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Italy: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Italy: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Spain: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Spain: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Russia: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Russia: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Others: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Others: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Latin America: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Latin America: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Brazil: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Brazil: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Mexico: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Mexico: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Others: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Others: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Middle East and Africa: Cardiac Prosthetic Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Middle East and Africa: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Global: Cardiac Prosthetic Devices Industry: SWOT Analysis
  • Figure 72: Global: Cardiac Prosthetic Devices Industry: Value Chain Analysis
  • Figure 73: Global: Cardiac Prosthetic Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cardiac Prosthetic Devices Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Cardiac Prosthetic Devices Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: Cardiac Prosthetic Devices Market Forecast: Breakup by End-User (in Million US$), 2023-2028
  • Table 4: Global: Cardiac Prosthetic Devices Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 5: Global: Cardiac Prosthetic Devices Market: Competitive Structure
  • Table 6: Global: Cardiac Prosthetic Devices Market: Key Players